Association of cardiac changes with serum adiponectin and resistin levels in obese and overweight children

Journal of Cardiovascular Medicine

Volumn 14, Issue 3, 2013, Pages 228-234

  Aknc, Ayşehan ^a   Karakurt, Cemsit ^b   Gurbuz, Sibel ^b   Elkran, Ozlem ^b   Nalbantoglu, Ozlem ^a   Kocak, Gulendam ^b   Guldur, Tayfun ^b   Yologlu, Saim ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Department of Pediatric Cardiology ^*  (Turkey)

Author keywords

Adiponectin; Cardiac changes; Childhood obesity; Resistin

Indexed keywords

ADIPONECTIN; C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIAL STIFFNESS; ARTICLE; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TISSUE DOPPLER IMAGING; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ANTHROPOMETRY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; OBESITY; OVERWEIGHT; RESISTIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84874666908     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328351674e     Document Type: Article

References (48)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organisation Technical Report Series 8941-253. Geneva: WHO; 2000.
2. Goran MI, Gower BA. Abdominal obesity and cardiovascular risk in children. Coron Artery Dis 1998; 9:483-487.
3. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002; 15:487-492.
4. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003; 107:1448-1453.
5. Martorell R, Kettel Khan L, Hughes ML, Grummer-Strawn LM. Overweight and obesity in preschool children from developing countries. Int J Obes Relat Metab Disord 2000; 24:959-967.
6. Messerli FH, Sundgaard-Riise K, Reisin ED, et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983; 99:757-761.
7. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358:1400-1404.
8. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13:18-23.
9. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24:29-33.
10. Matsushita K, Yatsuya H, Tamakoshi K, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26:871-876.
11. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312.
12. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50:2199-2202.
13. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285:561-564.
14. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 1:997-1001.
15. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362-2374.
16. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
17. Madeira IR, Carvalho CN, Gazolla FM, et al. Cut-off point for homeostatic model assessment for insulin resistance (HOMA-IR) index established from receiver operating characteristic (ROC) curve in the detection of metabolic syndrome in overweight prepubertal children. Arq Bras Endocrinol Metabol 2008; 52:1466-1473.
18. Lee YS. Consequences of childhood obesity. Ann Acad Med Singapore 2009; 38:75-81.
19. Wong CY, O'Moore-Sullivan T, Leano R, et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110:3081-3087.
20. Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 2004; 110:3488-3492.
21. Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006; 47:2267-2273.
22. Launer MS, Launer MF, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham heart study. J Am Coll Cardiol 1992; 19:130-134.
23. Grossman E, Grossman EF, Oren S, et al. Left ventricular filling in the systemic hypertension of obesity. Am J Cardiol 1991; 68:57-60.
24. Alpert MA, Terry BE, Terry BF, et al. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985; 55:783-786.
25. Pascual M, Pascual DA, Soria F, et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003; 89:1152-1156.
26. Van Putte-Katier N, Rooman RP, Haas L, et al. Early cardiac abnormalities in obese children: Importance of obesity per se versus associated cardiovascular risk factors. Pediatr Res 2008; 64:205-209.
27. Harada K, Orino T, Takada G. Body mass index can predict left ventricular diastolic filling in asymptomatic obese children. Pediatr Cardiol 2001; 22:273-278.
28. 2. Am J Pediatr Cardiol 2004; 93:1567-1569.
29. Pascual M, Pascual DA, Soria F. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003; 89:1152-1156.
30. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004; 43:1399-1404.
31. Sason Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88:1431-1436.
32. Urbina EM, Gidding SS, Bao W, et al.Associationof fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: the Bogalusa Heart Study. Am Heart J 1999; 138:122-127.
33. Nedvidkova J, Smitka K, Kopsky V, Hainer V. Adiponectin: an adipocyte-derived protein. Physiol Res 2005; 54:133-140.
34. Nishimura R, Sano H, Matsudaira T, et al. Childhood obesity and its relation to serum adiponectin and leptin: a report from a population-based study. Diabetes Res Clin Pract 2007; 76:245-250.
35. Winer JC, Zern TL, Taksali SE, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006; 91:4415-4423.
36. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, et al. Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 2008; 47:356-362.
37. Stefan N, Bunt CJ, Salbe AD, et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002; 87:4652-4656.
38. Hong SJ, Park CG, Seo HS, et al. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press 2004; 13:236-242.
39. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88:5452-5455.
40. Smith SR, Bai F, Charbonneau C, et al. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52:1611-1617.
41. Asano H, Izawa H, Nagata K, et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2009; 53:234-246.
42. Way JM, Gö rgün CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and simulated by peroxisome proliferator-activated receptor g agonist. J Biol Chem 2001; 276:25651-25653.
43. Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 2002; 10:1095-1103.
44. Janke J, Engeli S, Gorzelniak K, et al. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10:61-62.
45. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88:4848-4856.
46. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149:331-335.
47. Gerber M, Boettner A, Seidel B, et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005; 90:4503-4509.
48. Kim M, Oh JK, Sakata S, et al. Role of resistin in cardiac contractility and hypertrophy. J Mol Cell Cardiol 2008; 45:270-280.